Other biomarkers identified in the literature correlating MetS and NAFLD/NASH include: increased levels of IL-6, leptin, and TNF-α as well as decreased levels of adiponectin [89–91]. This evidence concerns the gene LEP and metabolic dysfunction-associated steatotic liver disease.